GO:0014906 myotube cell development involved in skeletal muscle regeneration: Regeneration Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0014906 describes the full developmental progression of a myotube cell, from fate commitment to a fully functional differentiated multinucleated cell, specifically within the context of skeletal muscle regeneration.
• Myotubes form when proliferating myoblasts exit the cell cycle, differentiate, and fuse; this process is the central cellular event of regenerating skeletal muscle.
• The process is orchestrated by myogenic regulatory factors (MYOD1, MYF5, MYOG, MYF6) and modulated by non-coding RNAs and signaling pathways.
• Defects in myotube development contribute to muscle disease, including myotonic dystrophy and age-related sarcopenia, and impair recovery after nerve injury.
• GO:0014906 is studied with lineage tracing, fusion assays, transcriptomics, and CRISPR-based perturbation of candidate genes.
• EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models and CRISPR library screening to dissect this regeneration-specific myotube program.
Description
Skeletal muscle is a highly regenerative tissue, and its repair after injury depends on the coordinated activation, proliferation, and differentiation of muscle stem cells. GO:0014906, myotube cell development involved in skeletal muscle regeneration, captures the specific developmental trajectory by which committed myoblasts become fully functional multinucleated myotubes during regeneration. This term is distinct from general myogenesis because it is explicitly contextualized to the regenerative response, a setting in which inflammatory, vascular, and neural cues shape the myogenic program. For researchers, GO:0014906 provides a precise annotation target for interpreting transcriptomic and proteomic data from injured or diseased muscle, and for designing experiments that test whether a gene is required for regeneration rather than for embryonic development. Because myotube development is the point at which mononuclear precursors commit irreversibly to a contractile fate, it is also a focal point for therapeutic strategies aimed at restoring muscle mass and function in myopathies, sarcopenia, and after peripheral nerve injury.
myotube cell development involved in skeletal muscle regeneration At A Glance
| GO ID | GO:0014906 |
|---|---|
| GO term | myotube cell development involved in skeletal muscle regeneration |
| Ontology | biological_process |
| Synonym | none |
| Major function | Progression of a myotube cell from fate commitment to fully functional differentiated multinucleated cell during skeletal muscle regeneration |
| Parent process | Skeletal muscle regeneration and muscle cell development |
| Cellular context | Regenerating skeletal muscle tissue; myoblasts and nascent myotubes |
| Key regulators | Myogenic regulatory factors (MYOD1, MYF5, MYOG, MYF6) and non-coding RNAs |
| Disease relevance | Myotonic dystrophy, sarcopenia, impaired reinnervation after nerve injury |
What Is GO:0014906?
GO:0014906 is a biological process term defined as the progression of a myotube cell over time, from the initial commitment of the cell to a specific fate through to the fully functional differentiated cell, occurring as part of skeletal muscle regeneration. Myotubes are multinucleated cells formed when proliferating myoblasts exit the cell cycle, differentiate, and fuse. In practical terms, the term encompasses the commitment of myogenic precursors, their withdrawal from the cell cycle, expression of muscle-specific structural genes, and the membrane fusion events that generate multinucleated syncytia within regenerating muscle.
Why Is myotube cell development involved in skeletal muscle regeneration Important in Cell Biology?
GO:0014906 matters because it defines the regenerative-specific myotube program that determines whether injured skeletal muscle successfully rebuilds contractile tissue or instead undergoes fibrosis and functional loss. Unlike developmental myogenesis, regeneration-specific myotube development occurs in an adult tissue environment influenced by immune signaling, vascular remodeling, and reinnervation. Consequently, genes annotated to this term are prime candidates for understanding muscle disease and for developing interventions that enhance repair in conditions such as myotonic dystrophy, age-related muscle loss, and denervation injury.
• Defines the core cellular event of skeletal muscle regeneration, linking stem cell activation to functional contractile tissue.
• Provides a precise annotation for interpreting regeneration-specific transcriptomes and proteomes.
• Highlights myogenic regulatory factors and non-coding RNAs as therapeutic targets.
• Explains why regeneration fails in myotonic dystrophy, where myogenesis and regeneration are abnormal.
• Connects muscle repair to neural input, as reinnervation is required for maintained muscle function.
• Supports research on sarcopenia and exercise-mediated reinnervation in elderly people.
• Offers a framework for testing gene causality using CRISPR knockout and knock-in models.
• Enables cross-species comparison of muscle regeneration mechanisms.
• Guides development of cell-based therapies for volumetric muscle loss and myopathies.
• Underpins bioinformatic enrichment analyses that identify regeneration-associated gene modules.
What Happens During myotube cell development involved in skeletal muscle regeneration?
Commitment of myogenic precursors
In simple terms: Muscle stem cells decide to become muscle cells.
In regenerating skeletal muscle, satellite cells and other myogenic precursors become committed to the myogenic lineage, a step governed by myogenic regulatory factors such as MYOD1 and MYF5. This commitment occurs in response to injury signals and is a prerequisite for the subsequent progression of myotube development. The regenerative context distinguishes this commitment from embryonic myogenesis, because adult regeneration integrates inflammatory and vascular cues.
Cell cycle exit and differentiation
In simple terms: The cells stop dividing and start becoming muscle.
Committed myoblasts exit the cell cycle and initiate differentiation, a transition marked by expression of MYOG and MYF6 and by the activation of muscle-specific structural genes. This step is essential for the progression of a myotube cell toward the fully functional differentiated state described by GO:0014906. Non-coding RNAs, including circular RNAs, modulate this differentiation program in myogenesis.
Myoblast fusion and multinucleation
In simple terms: Many small cells merge into one large muscle cell with many nuclei.
Differentiating myoblasts fuse to form multinucleated myotubes, the defining morphological event of myotube development. Fusion requires coordinated membrane remodeling and is followed by the assembly of contractile apparatus, yielding a functional differentiated cell. This fusion step is a central feature of regeneration-specific myotube development and is frequently assessed experimentally as an index of regenerative capacity.
Maturation into functional myotubes
In simple terms: The new muscle cell matures and becomes ready to contract.
After fusion, nascent myotubes mature by expressing contractile proteins and organizing sarcomeres, progressing to the fully functional differentiated cell that defines the endpoint of GO:0014906. Maturation in the regenerative setting is influenced by fiber-type specification and by the return of neural input, which supports long-term muscle function. Exercise and reinnervation can further modulate this maturation in aged muscle.
Integration with the regenerative niche
In simple terms: The new muscle cells must fit into the healing tissue environment.
Myotube development during regeneration does not occur in isolation; it is coordinated with immune, vascular, and neural remodeling within the injured muscle. Reinnervation after peripheral nerve injury is required for maintained muscle function and can be enhanced by skeletal muscle reprogramming. In elderly people, exercise-mediated reinnervation supports muscle maintenance, illustrating the integration of myotube development with systemic and neural factors.
Key Genes Involved in GO:0014906 myotube cell development involved in skeletal muscle regeneration
The following genes and proteins are established contributors to myotube cell development involved in skeletal muscle regeneration, based on their roles in myogenesis, regeneration, and related muscle biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYOD1 | Myogenic regulatory factor driving commitment and differentiation | Core marker of myogenic commitment in regeneration |
| MYF5 | Myogenic determination factor in precursor commitment | Target for lineage and knockout studies |
| MYOG | Regulator of terminal differentiation and fusion | Key marker of myotube formation |
| MYF6 | Myogenic factor supporting differentiation and maturation | Candidate for differentiation-stage studies |
| PAX7 | Satellite cell maintenance and activation | Relevant to regenerative precursor pool |
| MEF2C | Transcription factor cooperating with myogenic factors | Modulator of differentiation programs |
| IGF1 | Growth factor promoting myoblast differentiation and fusion | Anabolic regulator of myotube development |
| MSTN | Negative regulator of muscle growth | Target for enhancing muscle regeneration |
| FOXO1 | Transcription factor linked to muscle atrophy programs | Connects regeneration to catabolic signaling |
| PDK4 | Kinase promoting ubiquitin-proteasome-dependent atrophy | Links metabolic stress to muscle loss |
| DMD | Structural protein of the muscle cytoskeleton | Disease gene affecting muscle integrity |
| DMPK | Kinase whose dysfunction causes myotonic dystrophy | Disease gene with abnormal myogenesis |
| MBNL1 | RNA-binding regulator of alternative splicing | Modulates myogenesis and regeneration |
| CELF1 | RNA-binding protein affecting muscle differentiation | Implicated in myotonic dystrophy myogenesis defects |
| CircRNAs (e.g., circRNAs in myogenesis) | Non-coding regulators of myogenic differentiation | Emerging modulators of myotube development |
| MYH isoforms | Contractile proteins defining fiber type | Markers of myotube maturation |
| NRG1/ERBB signaling components | Neural-derived signals supporting reinnervation | Relevant to regeneration and reinnervation |
How Is myotube cell development involved in skeletal muscle regeneration Regulated?
Myotube cell development involved in skeletal muscle regeneration is regulated at multiple levels. Myogenic regulatory factors form a transcriptional network that controls commitment, differentiation, and fusion. Non-coding RNAs, including circular RNAs, add a post-transcriptional layer of control over myogenesis. Metabolic and catabolic signaling also influences the regenerative outcome; for example, PDK4 promotes ubiquitin-proteasome system-dependent muscle atrophy, which can oppose the accumulation of functional myotubes. Neural input and reinnervation are additional regulators, as skeletal muscle reprogramming can enhance reinnervation after peripheral nerve injury, and exercise-mediated reinnervation supports muscle maintenance in elderly people.
myotube cell development involved in skeletal muscle regeneration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DMPK | Myotonic dystrophy with abnormal myogenesis and regeneration | Knockout or knock-in of expanded repeats in myoblast lines |
| MBNL1 | RNA mis-splicing in myotonic dystrophy affecting differentiation | Knockout and rescue in differentiated myotubes |
| PDK4 | Ubiquitin-proteasome-dependent muscle atrophy | Overexpression and knockout in muscle cells |
| DMD | Muscle integrity and regeneration defects | Knockout in myogenic cell models |
| NRG1/ERBB components | Reinnervation after peripheral nerve injury | Knockout and overexpression in co-culture systems |
Myotonic dystrophy
Myotonic dystrophy is characterized by abnormalities in skeletal muscle myogenesis, growth, and regeneration, including defective myotube formation. The disease involves dysregulation of RNA-binding proteins such as MBNL1 and CELF1, which impairs the differentiation program required for functional myotubes. Studying GO:0014906 in this context helps identify which steps of myotube development are disrupted and how they might be restored.
Sarcopenia and age-related muscle loss
Age-related muscle loss is associated with impaired regenerative capacity and altered reinnervation. Exercise-mediated reinnervation supports skeletal muscle maintenance in elderly people, indicating that neural and myogenic components of regeneration are coupled. Understanding myotube development in this setting may inform interventions that preserve muscle mass with age.
Peripheral nerve injury and denervation
After peripheral nerve injury, muscle function depends on reinnervation, and skeletal muscle reprogramming can enhance reinnervation. Because myotube development is part of the regenerative response, impaired reinnervation can compromise the maturation and maintenance of regenerated myotubes. This links GO:0014906 to neuro-muscular repair strategies.
Muscle atrophy and catabolic signaling
Catabolic pathways that drive muscle atrophy can counteract the accumulation of functional myotubes. PDK4 promotes ubiquitin-proteasome system-dependent muscle atrophy, illustrating how metabolic kinases can negatively influence muscle mass. This highlights the need to consider atrophy signaling when studying regeneration-specific myotube development.
From myotube cell development involved in skeletal muscle regeneration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for myotube fusion? | CRISPR knockout in myoblast cell line followed by differentiation assay |
| Does a specific point mutation alter myogenic differentiation? | Point-mutation knock-in in myoblasts |
| Does a disease-associated variant affect myotube maturation? | Knock-in of the variant with isogenic control |
| Where and when is a protein expressed during regeneration? | Tagged knock-in for imaging and proteomics |
| Does overexpression of a factor enhance myotube formation? | Overexpression cell model with differentiation readouts |
| Which genes are essential for regeneration-specific myotube development? | CRISPR library screening in myogenic cells |
How to Study the myotube cell development involved in skeletal muscle regeneration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome changes during differentiation | Identifying regeneration-associated gene modules |
| Fusion index microscopy | Multinucleation and myotube formation | Testing genetic perturbations of fusion |
| Proteomics | Protein expression and maturation markers | Characterizing myotube maturation |
| Immunofluorescence | Localization of myogenic factors and structural proteins | Validating differentiation states |
| CRISPR knockout | Loss-of-function effects on myotube development | Testing gene requirement |
| Overexpression | Gain-of-function effects on differentiation | Testing sufficiency of a factor |
| In vivo injury models | Regeneration capacity in tissue context | Assessing myotube development in situ |
| Reinnervation assays | Neural input to regenerating muscle | Linking myotube development to nerve repair |
Transcriptomic profiling of myogenic differentiation
RNA-seq of myoblasts undergoing differentiation can identify genes and non-coding RNAs whose expression changes during myotube development. Such datasets can be interrogated for enrichment of GO:0014906, providing a regeneration-relevant view of the myogenic program. Circular RNAs, for example, have been profiled in myogenesis and implicated in differentiation control.
Fusion and morphological assays
Myotube formation is assessed by microscopy-based fusion indices and by measuring multinucleation, which directly reflects the fusion step of GO:0014906. These assays are used to test whether genetic perturbations alter the progression from myoblast to functional myotube.
Protein and post-transcriptional analyses
Proteomics and targeted protein assays can quantify contractile and regulatory proteins during myotube maturation. Because non-coding RNAs modulate myogenesis, post-transcriptional analyses are also informative for this process.
In vivo regeneration models
Injury-induced regeneration models allow assessment of myotube development in the native tissue context, including interactions with immune and neural cells. Reinnervation studies after peripheral nerve injury provide a complementary in vivo setting.
How CRISPR Can Be Used to Study GO:0014906 myotube cell development involved in skeletal muscle regeneration
Knockout
CRISPR knockout of candidate genes in myogenic cells enables loss-of-function tests of whether a gene is required for myotube development involved in skeletal muscle regeneration. Knockout models can be differentiated and scored for fusion and maturation defects, providing causal evidence for gene function in this process.
Point Mutation
Point-mutation knock-in allows modeling of specific variants suspected to affect myogenic differentiation or fusion. Such models are useful for distinguishing pathogenic variants from benign polymorphisms in genes linked to muscle disease.
Knock-in
Knock-in of tags or reporters supports visualization and biochemical analysis of proteins during myotube development. This approach can reveal when and where a factor acts during regeneration-specific differentiation.
Overexpression
Overexpression models test whether increased levels of a factor enhance or perturb myotube formation and maturation. They complement knockout studies by establishing sufficiency in the myogenic program.
How EDITGENE Supports myotube cell development involved in skeletal muscle regeneration Research
Researchers studying myotube cell development involved in skeletal muscle regeneration-related genes often need to determine whether a candidate gene is causally involved in myoblast commitment, differentiation, fusion, or maturation. EDITGENE provides the cell-model and screening tools required to move from correlation to causation in this regeneration-specific process.
Contact EDITGENE today to design your custom CRISPR model for myotube cell development involved in skeletal muscle regeneration research.
Frequently Asked Questions About myotube cell development involved in skeletal muscle regeneration
What is GO:0014906?
GO:0014906 is the biological process term for myotube cell development involved in skeletal muscle regeneration, describing the progression of a myotube cell from fate commitment to a fully functional differentiated cell during muscle regeneration.
What is a myotube?
A myotube is a multinucleated cell formed when proliferating myoblasts exit the cell cycle, differentiate, and fuse, and it is the central cell type produced during skeletal muscle regeneration.
What genes are involved in myotube cell development involved in skeletal muscle regeneration?
Key genes include myogenic regulatory factors such as MYOD1, MYF5, MYOG, and MYF6, along with modulators like PAX7, MEF2C, IGF1, and non-coding RNAs.
How is myotube development different in regeneration versus development?
Regeneration-specific myotube development occurs in adult tissue and integrates injury, immune, vascular, and neural cues, whereas developmental myogenesis follows a programmed embryonic trajectory.
Which diseases involve defective myotube development?
Myotonic dystrophy features abnormal myogenesis and regeneration, and age-related muscle loss and denervation injury also impair regenerative myotube formation.
What methods are used to study GO:0014906?
Common methods include RNA-seq, fusion-index microscopy, proteomics, immunofluorescence, CRISPR perturbation, and in vivo regeneration models.
Can CRISPR be used to study myotube development?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of genes in myotube development, and library screens can identify new regulators.
What is the role of non-coding RNAs in myotube development?
Circular RNAs and other non-coding RNAs modulate myogenic differentiation and are emerging regulators of myotube development.
Why is reinnervation important for myotube development?
Reinnervation provides neural input needed for maintained muscle function, and enhancing reinnervation after nerve injury supports regenerated muscle.
How does muscle atrophy signaling affect myotube development?
Catabolic pathways such as PDK4-driven ubiquitin-proteasome signaling promote muscle atrophy and can oppose the accumulation of functional myotubes.
Conclusion
GO:0014906 provides a precise, regeneration-contextualized definition of myotube cell development, from myoblast commitment through fusion and maturation into functional multinucleated cells. Because this process is central to muscle repair and is disrupted in diseases such as myotonic dystrophy and in age-related or denervation-related muscle loss, it is a high-value target for mechanistic and therapeutic research. CRISPR-based cell models and screening approaches now make it feasible to test candidate genes causally within this specific regenerative program.
References
- 1. Schiaffino S et al.. 2011. Fiber types in mammalian skeletal muscles.. Physiol Rev 91(4):1447-531 PMID: 22013216
- 2. Coletti C et al.. 2022. Exercise-mediated reinnervation of skeletal muscle in elderly people: An update.. Eur J Transl Myol 32(1) PMID: 35234025
- 3. Sinam IS et al.. 2022. Pyruvate dehydrogenase kinase 4 promotes ubiquitin-proteasome system-dependent muscle atrophy.. J Cachexia Sarcopenia Muscle 13(6):3122-3136 PMID: 36259412
- 4. Mehrotra P et al.. 2024. Skeletal muscle reprogramming enhances reinnervation after peripheral nerve injury.. Nat Commun 15(1):9218 PMID: 39455585
- 5. Das A et al.. 2020. Circular RNAs in myogenesis.. Biochim Biophys Acta Gene Regul Mech 1863(4):194372 PMID: 30946990
- 6. André LM et al.. 2018. Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.. Front Neurol 9:368 PMID: 29892259
- 7. Grefte S et al.. 2007. Skeletal muscle development and regeneration.. Stem Cells Dev 16(5):857-68 PMID: 17999606
- 8. Endo T. 2015. Molecular mechanisms of skeletal muscle development, regeneration, and osteogenic conversion.. Bone 80:2-13 PMID: 26453493
